25I-NBF

From WikiMD's Medical Encyclopedia

Revision as of 03:28, 13 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


25I-NBF[edit]

Chemical structure of 25I-NBF

25I-NBF is a synthetic compound that belongs to the class of phenethylamines. It is a derivative of the 2C family of psychedelic phenethylamines and is closely related to 25I-NBOMe, a more well-known compound in the same series. 25I-NBF is known for its potent serotonin receptor agonist activity, particularly at the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects.

Chemical Structure and Properties[edit]

25I-NBF is chemically known as 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine. The compound features a phenethylamine core with a 4-iodo-2,5-dimethoxy substitution pattern on the phenyl ring, similar to other compounds in the 25I series. The N-benzyl group is substituted with a fluorine atom, distinguishing it from other analogs such as 25I-NBOMe, which has a methoxy group instead.

Pharmacology[edit]

25I-NBF acts primarily as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is associated with the psychedelic effects experienced by users. The compound may also interact with other serotonin receptor subtypes, but its affinity and activity at these sites are less well characterized.

Effects[edit]

The effects of 25I-NBF are similar to those of other psychedelic phenethylamines, including altered perception, visual hallucinations, and changes in thought processes. The intensity and duration of these effects can vary depending on the dose and individual sensitivity. As with other psychedelics, the experience can be influenced by the user's set and setting.

Safety and Toxicity[edit]

The safety profile of 25I-NBF is not well established, as it is a relatively new compound with limited research. However, compounds in the 25I series have been associated with adverse effects, including vasoconstriction, tachycardia, and hypertension. There have been reports of severe toxicity and fatalities associated with the use of related compounds, highlighting the potential risks of using 25I-NBF.

Legal Status[edit]

The legal status of 25I-NBF varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated compounds. Users should be aware of the legal implications of possessing or distributing 25I-NBF in their region.

Related Compounds[edit]

See Also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.